PI
GSK icon

PEAK6 Investments’s GSK GSK Stock Holding History

PEAK6 Investments’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,206
Closed -$49.7K – 4286
2023
Q4 		$44.7K Buy
+1,206
New +$43.3K ﹤0.01% 3781
2023
Q2 		– Sell
-15,002
Closed -$534K – 4206
2023
Q1 		$534K Sell
15,002
-146,766
-91% -$5.13M ﹤0.01% 2342
2022
Q4 		$5.68M Sell
161,768
-85,901
-35% -$2.86M 0.03% 657
2022
Q3 		$7.29M Buy
+247,669
New +$9.39M 0.03% 597
2021
Q1 		– Sell
-42,704
Closed -$1.96M – 5104
2020
Q4 		$1.96M Buy
42,704
+14,597
+52% +$671K ﹤0.01% 1866
2020
Q3 		$1.32M Buy
+28,107
New +$1.41M ﹤0.01% 2022
2019
Q1 		– Sell
-55,425
Closed -$2.77M – 4120
2018
Q4 		$2.65M Buy
+55,425
New +$2.73M 0.02% 1036

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

PEAK6 Investments's GSK Position: Q1 2024 in Review

PEAK6 Investments sold out of GSK (GSK) in Q1 2024, closing a stake of 1,206 shares — an estimated $49.7K sold.

PEAK6 Investments first reported a position in GSK in Q4 2018 and held it in 7 quarters. The position peaked at $7.29M in Q3 2022. 910 funds tracked by Wall St. Rank hold GSK as of Q1 2024.

  • PEAK6 Investments reported no remaining GSK position as of Q1 2024 after selling out during the quarter.
  • PEAK6 Investments sold 1,206 GSK shares in Q1 2024, an estimated $49.7K.
  • PEAK6 Investments first reported a position in GSK in Q4 2018 and held it in 7 quarters.
  • PEAK6 Investments's GSK position peaked at $7.29M in Q3 2022.
  • 910 funds tracked by Wall St. Rank held GSK as of Q1 2024.

Based on PEAK6 Investments's 13F filing for Q1 2024, filed 14 May 2024.